March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same ...
Whether you’re trying to prevent blood clots or have been prescribed a blood thinner to treat atrial fibrillation (AFib), ...
Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.Despite higher medication adherence to ...
16d
Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications
Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding ...
THIRD APPROVAL: Regulators in Japan have approved anticlotting drug called Eliquis, a potential blockbuster from Bristol-Myers Squibb and Pfizer. It’s already on sale in Canada and the European Union.
The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results